Back

Study protocol: Medium throughput proteomic characterization of children with PIMS-TS, and identification of candidate diagnostic biomarkers.

Roarty, C.; Mills, C.; Tonry, C.; Cosgrove, P.; Norman-Bruce, H.; Groves, H.; Watson, C.; Waterfield, T.

2022-12-28 pediatrics
10.1101/2022.12.27.22283890 medRxiv
Show abstract

SARS-CoV-2 infection in children results in a wide range of clinical outcomes. Paediatric Multisystem Inflammatory syndrome temporally associated with COVID-19(PIMS-TS) occurs weeks after a SARS-CoV-2 infection, and results in severe illness. This protocol describes a study to fully characterize the circulating proteome of children who have PIMS-TS, the proteome of healthy children who have previously been infected with SARS-CoV-2 and the proteome of febrile children with a confirmed invasive infection. Orthogonal proteomic techniques will be utilized to provide a deep proteomic characterization.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.